Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 1
R&D Momentum
75/100
Pipeline Velocity
48/100
Trial Completion Rate
55/100
Pipeline Concentration
63/100
Pipeline Freshness
53/100
Strategic Signals
Activity
Last 14 days
Increasing Cancer Screening Among Female Patients at PSH St. Joseph's Residency Clinic: Offering a Self-sampling Option in Clinic
Diagnostic and Prognostic Biomarkers to Elucidate Sepsis Endotypes
Predicting Concussion Outcomes With Salivary miRNA
SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations: a Cluster, Randomized Controlled Trial
Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)